CLINICAL_TRIALS
trial_result
· 2013-04-15
Clinical Trial Update: The HAM Infliximab Study [Phase 2]
Summary
A Phase 2 trial of infliximab for HTLV-I-associated myelopathy has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Imperial College London | Conditions: HTLV-I-associated Myelopathy | Phase 2 | Status: TERMINATED